BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 24435810)

  • 1. Serum levels of arachidonic acid metabolites change during prostate cancer progression.
    Rodríguez-Blanco G; Burgers PC; Dekker LJ; Ijzermans JJ; Wildhagen MF; Schenk-Braat EA; Bangma CH; Jenster G; Luider TM
    Prostate; 2014 May; 74(6):618-27. PubMed ID: 24435810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated 12- and 20-hydroxyeicosatetraenoic acid in urine of patients with prostatic diseases.
    Nithipatikom K; Isbell MA; See WA; Campbell WB
    Cancer Lett; 2006 Feb; 233(2):219-25. PubMed ID: 15882928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biosynthesis of 12(S)-hydroxyeicosatetraenoic acid by B16 amelanotic melanoma cells is a determinant of their metastatic potential.
    Liu B; Marnett LJ; Chaudhary A; Ji C; Blair IA; Johnson CR; Diglio CA; Honn KV
    Lab Invest; 1994 Mar; 70(3):314-23. PubMed ID: 8145526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of cytochrome P450 metabolites of arachidonic acid in coronary venous plasma during ischemia and reperfusion in dogs.
    Nithipatikom K; DiCamelli RF; Kohler S; Gumina RJ; Falck JR; Campbell WB; Gross GJ
    Anal Biochem; 2001 May; 292(1):115-24. PubMed ID: 11319825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The enantioselective separation and quantitation of the hydroxy-metabolites of arachidonic acid by liquid chromatography - tandem mass spectrometry.
    Isse FA; Alammari AH; El-Sherbeni AA; Brocks DR; El-Kadi AOS
    Prostaglandins Other Lipid Mediat; 2023 Apr; 165():106701. PubMed ID: 36528330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in lipoxygenase and cyclooxygenase-2 catalytic activity and mRNA expression in prostate carcinoma.
    Shappell SB; Manning S; Boeglin WE; Guan YF; Roberts RL; Davis L; Olson SJ; Jack GS; Coffey CS; Wheeler TM; Breyer MD; Brash AR
    Neoplasia; 2001; 3(4):287-303. PubMed ID: 11571629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative serum levels of early prostate cancer antigen (EPCA) predict prostate cancer progression in patients undergoing radical prostatectomy.
    Zhao Z; Ma W; Zeng G; Qi D; Ou L; Liang Y
    Prostate; 2012 Feb; 72(3):270-9. PubMed ID: 21630293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 15S-Hydroxyeicosatetraenoic acid activates peroxisome proliferator-activated receptor gamma and inhibits proliferation in PC3 prostate carcinoma cells.
    Shappell SB; Gupta RA; Manning S; Whitehead R; Boeglin WE; Schneider C; Case T; Price J; Jack GS; Wheeler TM; Matusik RJ; Brash AR; Dubois RN
    Cancer Res; 2001 Jan; 61(2):497-503. PubMed ID: 11212240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex- and enantiospecific differences in the formation rate of hydroxyeicosatetraenoic acids in rat organs.
    Gerges SH; Alammari AH; El-Ghiaty MA; Isse FA; El-Kadi AOS
    Can J Physiol Pharmacol; 2023 Aug; 101(8):425-436. PubMed ID: 37220651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclooxygenase-2-mediated metabolism of arachidonic acid to 15-oxo-eicosatetraenoic acid by rat intestinal epithelial cells.
    Lee SH; Rangiah K; Williams MV; Wehr AY; DuBois RN; Blair IA
    Chem Res Toxicol; 2007 Nov; 20(11):1665-75. PubMed ID: 17910482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity is positively associated with arachidonic acid-derived 5- and 11-hydroxyeicosatetraenoic acid (HETE).
    Pickens CA; Sordillo LM; Zhang C; Fenton JI
    Metabolism; 2017 May; 70():177-191. PubMed ID: 28403941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 7-HETE, 10-HETE, and 13-HETE are major products of NADPH-dependent arachidonic acid metabolism in rat liver microsomes: analysis of their stereochemistry, and the stereochemistry of their acid-catalyzed rearrangement.
    Brash AR; Boeglin WE; Capdevila JH; Yeola S; Blair IA
    Arch Biochem Biophys; 1995 Aug; 321(2):485-92. PubMed ID: 7646075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated expression of 12/15-lipoxygenase and cyclooxygenase-2 in a transgenic mouse model of prostate carcinoma.
    Shappell SB; Olson SJ; Hannah SE; Manning S; Roberts RL; Masumori N; Jisaka M; Boeglin WE; Vader V; Dave DS; Shook MF; Thomas TZ; Funk CD; Brash AR; Matusik RJ
    Cancer Res; 2003 May; 63(9):2256-67. PubMed ID: 12727848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of arachidonic acid metabolites on the control of non-differentiated intestinal epithelial cell growth.
    Cabral M; Martín-Venegas R; Moreno JJ
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1620-8. PubMed ID: 23685077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association analysis of Wnt pathway genes on prostate-specific antigen recurrence after radical prostatectomy.
    Huang SP; Ting WC; Chen LM; Huang LC; Liu CC; Chen CW; Hsieh CJ; Yang WH; Chang TY; Lee HZ; Bao BY
    Ann Surg Oncol; 2010 Jan; 17(1):312-22. PubMed ID: 19777185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and pathological characteristics of patients presenting with biochemical progression after radical retropubic prostatectomy for pathologically organ-confined prostate cancer.
    Pinto F; Prayer-Galetti T; Gardiman M; Sacco E; Ciaccia M; Fracalanza S; Betto G; Pagano F
    Urol Int; 2006; 76(3):202-8. PubMed ID: 16601379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma hTERT mRNA discriminates between clinically localized and locally advanced disease and is a predictor of recurrence in prostate cancer patients.
    March-Villalba JA; Martínez-Jabaloyas JM; Herrero MJ; Santamaría J; Aliño SF; Dasí F
    Expert Opin Biol Ther; 2012 Jun; 12 Suppl 1():S69-77. PubMed ID: 22559196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-dopa decarboxylase (DDC) gene expression is related to outcome in patients with prostate cancer.
    Koutalellis G; Stravodimos K; Avgeris M; Mavridis K; Scorilas A; Lazaris A; Constantinides C
    BJU Int; 2012 Sep; 110(6 Pt B):E267-73. PubMed ID: 22571720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the content differences of arachidonic acid metabolites in a mouse model of breast cancer by using LC-MS/MS.
    Chen A; Zhang Y; Sun D; Xu Y; Guo Y; Wang X
    J Pharm Biomed Anal; 2021 Feb; 194():113763. PubMed ID: 33279296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous quantification of arachidonic acid metabolites in cultured tumor cells using high-performance liquid chromatography/electrospray ionization tandem mass spectrometry.
    Kempen EC; Yang P; Felix E; Madden T; Newman RA
    Anal Biochem; 2001 Oct; 297(2):183-90. PubMed ID: 11673886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.